<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34899999</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">1759-1961</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Clinical &amp; experimental neuroimmunology</Title><ISOAbbreviation>Clin Exp Neuroimmunol</ISOAbbreviation></Journal><ArticleTitle>Neuro-COVID-19.</ArticleTitle><Pagination><StartPage>17</StartPage><EndPage>23</EndPage><MedlinePgn>17-23</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/cen3.12676</ELocationID><Abstract><AbstractText>Neuromuscular manifestations of new coronavirus disease 2019 (COVID-19) infection are frequent, and include dizziness, headache, myopathy, and olfactory and gustatory disturbances. Patients with acute central nervous system disorders, such as delirium, impaired consciousness, stroke and convulsive seizures, have a high mortality rate. The encephalitis/encephalopathy that causes consciousness disturbance and seizures can be classified into three conditions, including direct infection with the SARS-CoV-2 virus, encephalopathy caused by central nervous system damage secondary to systemic hypercytokinemia (cytokine storm) and autoimmune-mediated encephalitis that occurs after infection. The sequelae, called post-acute COVID-19 syndrome or long COVID, include neuromuscular manifestations, such as anxiety, depression, sleep disturbance, muscle weakness, brain fog and cognitive impairment. It is desirable to establish diagnostic criteria and treatment for these symptoms. Vaccine-induced thrombotic thrombocytopenia, Guillain-Barr&#xe9; syndrome, bilateral facial paralysis, encephalitis and opsoclonus-myoclonus syndrome have been reported as adverse reactions after the COVID-19 vaccine, although these are rare.</AbstractText><CopyrightInformation>&#xa9; 2021 Japanese Society for Neuroimmunology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shimohata</LastName><ForeName>Takayoshi</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-8788-9089</Identifier><AffiliationInfo><Affiliation>Department of Neurology Gifu University Graduate School of Medicine Gifu Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Clin Exp Neuroimmunol</MedlineTA><NlmUniqueID>101520677</NlmUniqueID><ISSNLinking>1759-1961</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword><Keyword MajorTopicYN="N">neuromuscular manifestations</Keyword><Keyword MajorTopicYN="N">post&#x2010;acute COVID&#x2010;19 syndrome</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>13</Day><Hour>17</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34899999</ArticleId><ArticleId IdType="pmc">PMC8652810</ArticleId><ArticleId IdType="doi">10.1111/cen3.12676</ArticleId><ArticleId IdType="pii">CEN312676</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mao L, Jin H, Wang M, Hu YU, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero&#x2010;S&#xe1;nchez CM, D&#xed;az&#x2010;Maroto I, Fern&#xe1;ndez&#x2010;D&#xed;az E, S&#xe1;nchez&#x2010;Larsen &#xc1;, Layos&#x2010;Romero A, Garc&#xed;a&#x2010;Garc&#xed;a J, et al. Neurologic manifestations in hospitalized patients with COVID&#x2010;19: the ALBACOVID registry. Neurology. 2020;95:e1060&#x2013;e70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7668545</ArticleId><ArticleId IdType="pubmed">32482845</ArticleId></ArticleIdList></Reference><Reference><Citation>Moro E, Priori A, Beghi E, Helbok R, Campiglio L, Bassetti CL, et al. The international European Academy of Neurology survey on neurological symptoms in patients with COVID&#x2010;19 infection. Eur J Neurol. 2020;27:1727&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323212</ArticleId><ArticleId IdType="pubmed">32558002</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a&#x2010;Monc&#xf3; JC, Cabrera Muras A, Erburu Iriarte M, Rodrigo Armenteros P, Coll&#xed;a Fern&#xe1;ndez A, Arranz&#x2010;Mart&#xed;nez J, et al. Neurologic manifestations in a prospective unselected series of hospitalized patients with COVID&#x2010;19. Neurol Clin Pract. 2021;11:e64&#x2013;e72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8032434</ArticleId><ArticleId IdType="pubmed">33842073</ArticleId></ArticleIdList></Reference><Reference><Citation>Liotta EM, Batra A, Clark JR, Shlobin NA, Hoffman SC, Orban ZS, et al. Frequent neurologic manifestations and encephalopathy&#x2010;associated morbidity in Covid&#x2010;19 patients. Ann Clin Transl Neurol. 2020;7:2221&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7664279</ArticleId><ArticleId IdType="pubmed">33016619</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira V, Seabra M, Rodrigues R, Carvalho V, Mendes M, Pereira D, et al. Neuro&#x2010;COVID frequency and short&#x2010;term outcome in the Northern Portuguese population. Eur J Neurol. 2021;28:3360&#x2013;8. 10.1111/ene.14874</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14874</ArticleId><ArticleId IdType="pmc">PMC8250949</ArticleId><ArticleId IdType="pubmed">33884707</ArticleId></ArticleIdList></Reference><Reference><Citation>Hern&#xe1;ndez&#x2010;Fern&#xe1;ndez F, Sandoval Valencia H, Barbella&#x2010;Aponte RA, Collado&#x2010;Jim&#xe9;nez R, Ayo&#x2010;Mart&#xed;n &#xd3;, Barrena C, et al. Cerebrovascular disease in patients with COVID&#x2010;19: neuroimaging, histological and clinical description. Brain. 2020;143:3089&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454411</ArticleId><ArticleId IdType="pubmed">32645151</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannac O, Martinez&#x2010;Almoyna L, Hraiech S. Critical illness&#x2010;associated cerebral microbleeds in COVID&#x2010;19 acute respiratory distress syndrome. Neurology. 2020;95:498&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">32727834</ArticleId></ArticleIdList></Reference><Reference><Citation>Fridman S, Bres Bullrich M, Jimenez&#x2010;Ruiz A, Costantini P, Shah P, Just C, et al. Stroke risk, phenotypes, and death in COVID&#x2010;19: systematic review and newly reported cases. Neurology. 2020;95:e3373&#x2013;e85.</Citation><ArticleIdList><ArticleId IdType="pubmed">32934172</ArticleId></ArticleIdList></Reference><Reference><Citation>Siepmann T, Sedghi A, Simon E, Winzer S, Barlinn J, With K, et al. Increased risk of acute stroke among patients with severe COVID&#x2010;19: a multicenter study and meta&#x2010;analysis. Eur J Neurol. 2021;28:238&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">32920964</ArticleId></ArticleIdList></Reference><Reference><Citation>Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID&#x2010;19. Nat Rev Neurol. 2020;16:636&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7444680</ArticleId><ArticleId IdType="pubmed">32839585</ArticleId></ArticleIdList></Reference><Reference><Citation>Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5066574</ArticleId><ArticleId IdType="pubmed">26906964</ArticleId></ArticleIdList></Reference><Reference><Citation>Esp&#xed;ndola OM, Gomes YCP, Brand&#xe3;o CO, Torres RC, Siqueira M, Soares CN, et al. Inflammatory cytokine patterns associated with neurological diseases in coronavirus disease 2019. Ann Neurol. 2021;89:1041&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014707</ArticleId><ArticleId IdType="pubmed">33547819</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkady A, Rabinstein AA. Acute necrotizing encephalopathy and myocarditis in a young patient with COVID&#x2010;19. Neurology. 2020;7(5):e801</Citation></Reference><Reference><Citation>Paterson RW, Brown RL, Benjamin L, Nortley R, Wiethoff S, Bharucha T, et al. The emerging spectrum of COVID&#x2010;19 neurology: clinical, radiological and laboratory findings. Brain. 2020;143:3104&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi M, Sahashi Y, Baba Y, Okura H, Shimohata T. COVID&#x2010;19&#x2010;associated mild encephalitis/encephalopathy with a reversible splenial lesion. J Neurol Sci. 2020;415:116941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7251406</ArticleId><ArticleId IdType="pubmed">32474220</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishfy L, Casasola M, Banankhah P, Parvez A, Jan YJ, Shenoy AM, et al. Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid&#x2010;19. J Neurol Sci. 2020;414:116943.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7245308</ArticleId><ArticleId IdType="pubmed">32474362</ArticleId></ArticleIdList></Reference><Reference><Citation>Palao M, Fern&#xe1;ndez&#x2010;D&#xed;az E, Gracia&#x2010;Gil J, Romero&#x2010;S&#xe1;nchez CM, D&#xed;az&#x2010;Maroto I, Segura T. Multiple sclerosis following SARS&#x2010;CoV&#x2010;2 infection. Mult Scler Relat Disord. 2020;45:102377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7340057</ArticleId><ArticleId IdType="pubmed">32698095</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto AA, Carroll LS, Nar V, Varatharaj A, Galea I. CNS inflammatory vasculopathy with antimyelin oligodendrocyte glycoprotein antibodies in COVID&#x2010;19. Neurol Neuroimmunol Neuroinflamm. 2020;7:e813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7309522</ArticleId><ArticleId IdType="pubmed">32522768</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xe1;bano&#x2010;Su&#xe1;rez P, Bermejo&#x2010;Guerrero L, M&#xe9;ndez&#x2010;Guerrero A, Parra&#x2010;Serrano J, Toledo&#x2010;Alfocea D, S&#xe1;nchez&#x2010;Tejerina D, et al. Generalized myoclonus in COVID&#x2010;19. Neurology. 2020;95:e767&#x2013;e72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7455360</ArticleId><ArticleId IdType="pubmed">32439821</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah PB, Desai SD. Opsoclonus myoclonus ataxia syndrome in the setting of COVID&#x2010;19 infection. Neurology. 2021;96:33.</Citation><ArticleIdList><ArticleId IdType="pubmed">33004603</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xe9;ndez&#x2010;Guerrero A, Laespada&#x2010;Garc&#xed;a MI, G&#xf3;mez&#x2010;Grande A, Ruiz&#x2010;Ortiz M, Blanco&#x2010;Palmero VA, Azcarate&#x2010;Diaz FJ, et al. Acute hypokinetic&#x2010;rigid syndrome following SARS&#x2010;CoV&#x2010;2 infection. Neurology. 2020;95:e2109&#x2013;e18.</Citation><ArticleIdList><ArticleId IdType="pubmed">32641525</ArticleId></ArticleIdList></Reference><Reference><Citation>Oosthuizen K, Steyn EC, Tucker L, Ncube IV, Hardie D, Marais S. SARS&#x2010;CoV&#x2010;2 encephalitis presenting as a clinical cerebellar syndrome: a case report. Neurology. 2021;97:27&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">33853896</ArticleId></ArticleIdList></Reference><Reference><Citation>Hull M, Parnes M, Jankovic J. Increased Incidence of Functional (Psychogenic) movement disorders in children and adults amidst the COVID&#x2010;19 pandemic: a a cross&#x2010;sectional study. Neurol Clin Pract. 2021. 10.1212/CPJ.000000000000001082</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CPJ.000000000000001082</ArticleId><ArticleId IdType="pmc">PMC8610548</ArticleId><ArticleId IdType="pubmed">34840884</ArticleId></ArticleIdList></Reference><Reference><Citation>De Sanctis P, Doneddu PE, Vigan&#xf2; L, Selmi C, Nobile&#x2010;Orazio E. Guillain&#x2010;Barr&#xe9; syndrome associated with SARS&#x2010;CoV&#x2010;2 infection. A systematic review. Eur J Neurol. 2020;27:2361&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7436512</ArticleId><ArticleId IdType="pubmed">32757404</ArticleId></ArticleIdList></Reference><Reference><Citation>Filosto M, Cotti Piccinelli S, Gazzina S, Foresti C, Frigeni B, Servalli MC, et al. Guillain&#x2010;Barr&#xe9; syndrome and COVID&#x2010;19: an observational multicentre study from two Italian hotspot regions. J Neurol Neurosurg Psychiatry. 2021;92:751&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">33158914</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez&#x2010;Ortiz C, M&#xe9;ndez&#x2010;Guerrero A, Rodrigo&#x2010;Rey S, San Pedro&#x2010;Murillo E, Bermejo&#x2010;Guerrero L, Gordo&#x2010;Ma&#xf1;as R, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID&#x2010;19. Neurology. 2020;95:e601&#x2013;e5.</Citation><ArticleIdList><ArticleId IdType="pubmed">32303650</ArticleId></ArticleIdList></Reference><Reference><Citation>Derollez C, Alberto T, Leroi I, Mackowiak MA, Chen Y. Facial nerve palsy: an atypical clinical manifestation of COVID&#x2010;19 infection in a family cluster. Eur J Neurol. 2020;27:2670&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461229</ArticleId><ArticleId IdType="pubmed">32853484</ArticleId></ArticleIdList></Reference><Reference><Citation>Koumpa FS, Forde CT, Manjaly JG. Sudden irreversible hearing loss post COVID&#x2010;19. BMJ Case Rep. 2020;13:e238419.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7554505</ArticleId><ArticleId IdType="pubmed">33051251</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik GR, Wolfe AR, Soriano R, Rydberg L, Wolfe LF, Deshmukh S, et al. Injury&#x2010;prone: peripheral nerve injuries associated with prone positioning for COVID&#x2010;19&#x2010;related acute respiratory distress syndrome. Br J Anaesth. 2020;125:e478&#x2013;e80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7473147</ArticleId><ArticleId IdType="pubmed">32948295</ArticleId></ArticleIdList></Reference><Reference><Citation>Restivo DA, Centonze D, Alesina A, Marchese&#x2010;Ragona R. Myasthenia gravis associated with SARS&#x2010;CoV&#x2010;2 infection. Ann Intern Med. 2020;173:1027&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7429993</ArticleId><ArticleId IdType="pubmed">32776781</ArticleId></ArticleIdList></Reference><Reference><Citation>Assini A, Gandoglia I, Damato V, Rikani K, Evoli A, Del Sette M. Myasthenia gravis associated with anti&#x2010;MuSK antibodies developed after SARS&#x2010;CoV&#x2010;2 infection. Eur J Neurol. 2021;28:3537&#x2013;9. 10.1111/ene.14721</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14721</ArticleId><ArticleId IdType="pmc">PMC8014563</ArticleId><ArticleId IdType="pubmed">33421278</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Charmchi Z, Seidman RJ, Anziska Y, Velayudhan V, Perk J. COVID&#x2010;19&#x2010;associated myositis with severe proximal and bulbar weakness. Muscle Nerve. 2020;62:E57&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323133</ArticleId><ArticleId IdType="pubmed">32535934</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanboon J, Nishino I. COVID&#x2010;19&#x2010;associated myositis may be dermatomyositis. Muscle Nerve. 2021;63:E9&#x2013;E10.</Citation><ArticleIdList><ArticleId IdType="pubmed">33095493</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020;77:1018&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7484225</ArticleId><ArticleId IdType="pubmed">32469387</ArticleId></ArticleIdList></Reference><Reference><Citation>Daly JL, Simonetti B, Klein K, Chen K&#x2010;E, Williamson MK, Ant&#xf3;n&#x2010;Pl&#xe1;garo C, et al. Neuropilin&#x2010;1 is a host factor for SARS&#x2010;CoV&#x2010;2 infection. Science. 2020;370:861&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7612957</ArticleId><ArticleId IdType="pubmed">33082294</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS&#x2010;CoV2 may play a role in the respiratory failure of COVID&#x2010;19 patients. J Med Virol. 2020;92:552&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7228394</ArticleId><ArticleId IdType="pubmed">32104915</ArticleId></ArticleIdList></Reference><Reference><Citation>Matschke J, L&#xfc;tgehetmann M, Hagel C, Sperhake JP, Schr&#xf6;der AS, Edler C, et al. Neuropathology of patients with COVID&#x2010;19 in Germany: a post&#x2010;mortem case series. Lancet Neurol. 2020;19:919&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7535629</ArticleId><ArticleId IdType="pubmed">33031735</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng J, Wong L&#x2010;Y, Li K, Verma AK, Ortiz ME, Wohlford&#x2010;Lenane C, et al. COVID&#x2010;19 treatments and pathogenesis including anosmia in K18&#x2010;hACE2 mice. Nature. 2021;589:603&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7855185</ArticleId><ArticleId IdType="pubmed">33166988</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur KT, Miller EH, Glendinning MD, Al&#x2010;Dalahmah O, Banu MA, Boehme AK, et al. COVID&#x2010;19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain. 2021;awab148. 10.1093/brain/awab148</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab148</ArticleId><ArticleId IdType="pmc">PMC8083258</ArticleId><ArticleId IdType="pubmed">33856027</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang LU, Sievert D, Clark AE, Lee S, Federman H, Gastfriend BD, et al. A human three&#x2010;dimensional neural&#x2010;perivascular 'assembloid' promotes astrocytic development and enables modeling of SARS&#x2010;CoV&#x2010;2 neuropathology. Nat Med. 2021;27:1600&#x2013;6. 10.1038/s41591-021-01443-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01443-1</ArticleId><ArticleId IdType="pmc">PMC8601037</ArticleId><ArticleId IdType="pubmed">34244682</ArticleId></ArticleIdList></Reference><Reference><Citation>Ed&#xe9;n A, Kanberg N, Gostner J, Fuchs D, Hagberg L, Andersson LM, et al. CSF biomarkers in patients with COVID&#x2010;19 and neurologic symptoms: a case series. Neurology. 2021;96:e294&#x2013;300.</Citation><ArticleIdList><ArticleId IdType="pubmed">33004602</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhea EM, Logsdon AF, Hansen KM, Williams LM, Reed MJ, Baumann KK, et al. The S1 protein of SARS&#x2010;CoV&#x2010;2 crosses the blood&#x2010;brain barrier in mice. Nat Neurosci. 2021;24:368&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8793077</ArticleId><ArticleId IdType="pubmed">33328624</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. The unique characteristics of COVID&#x2010;19 coagulopathy. Crit Care. 2020;24:360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301352</ArticleId><ArticleId IdType="pubmed">32552865</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo YU, Estes SK, Ali RA, Gandhi AA, Yalavarthi S, Shi H, et al. Prothrombotic autoantibodies in serum from patients hospitalized with COVID&#x2010;19. Sci Transl Med. 2020;12:eabd3876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7724273</ArticleId><ArticleId IdType="pubmed">33139519</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC, Kern F, Losada PM, Agam MR, Maat CA, Schmartz GP, et al. Dysregulation of brain and choroid plexus cell types in severe COVID&#x2010;19. Nature. 2021;595:565&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, Dai Y, Huck JD, Jaycox JR, et al. Diverse functional autoantibodies in patients with COVID&#x2010;19. Nature. 2021;595:283&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwan NA. The road to addressing Long Covid. Science. 2021;373:491&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">34326224</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post&#x2010;acute COVID&#x2010;19 syndrome. Nat Med. 2021;27:601&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin&#x2010;Frankel J. The long haul. Science. 2020;369:614&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">32764050</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosp JA, Dressing A, Blazhenets G, Bormann T, Rau A, Schwabenland M, et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID&#x2010;19. Brain. 2021;144:1263&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8083602</ArticleId><ArticleId IdType="pubmed">33822001</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee for the COMEBAC Study Group , Morin L, Savale L, Pham T, Colle R, Figueiredo S, et al. Four&#x2010;month clinical status of a cohort of patients after hospitalization for COVID&#x2010;19. JAMA. 2021;325(15):1525&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7970386</ArticleId><ArticleId IdType="pubmed">33729425</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B, Mohn K&#x2010;I, Brokstad KA, Zhou F, Linchausen DW, Hansen B&#x2010;A, et al. Long COVID in a prospective cohort of home&#x2010;isolated patients. Nat Med. 2021;27:1607&#x2013;13. 10.1038/s41591-021-01433-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefano GB, B&#xfc;ttiker P, Weissenberger S, Martin A, Ptacek R, Kream RM. Editorial: the pathogenesis of long&#x2010;term neuropsychiatric COVID&#x2010;19 and the role of microglia, mitochondria, and persistent neuroinflammation: a hypothesis. Med Sci Monit. 2021;27:e933015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8120907</ArticleId><ArticleId IdType="pubmed">34016942</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratt J, Lester E, Parker R. Could SARS&#x2010;CoV&#x2010;2 cause tauopathy? Lancet Neurol. 2021;20:506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8292136</ArticleId><ArticleId IdType="pubmed">34146504</ArticleId></ArticleIdList></Reference><Reference><Citation>Balcom EF, Nath A, Power C. Acute and chronic neurological disorders in COVID&#x2010;19: potential mechanisms of disease. Brain. 2021:awab302. 10.1093/brain/awab302</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab302</ArticleId><ArticleId IdType="pmc">PMC8719840</ArticleId><ArticleId IdType="pubmed">34398188</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz NH, S&#xf8;rvoll IH, Michelsen AE, Munthe LA, Lund&#x2010;Johansen F, Ahlen MT, et al. Thrombosis and thrombocytopenia after ChAdOx1 nCoV&#x2010;19 vaccination. N Engl J Med. 2021;384:2124&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8112568</ArticleId><ArticleId IdType="pubmed">33835768</ArticleId></ArticleIdList></Reference><Reference><Citation>
Johnson &amp; Johnson Statement on COVID&#x2010;19 Vaccine (7/12) (https://www.jnj.com/johnson&#x2010;johnson&#x2010;july&#x2010;12&#x2010;statement&#x2010;on&#x2010;COVID&#x2010;19&#x2010;vaccine
</Citation></Reference><Reference><Citation>Allen CM, Ramsamy S, Tarr AW, Tighe PJ, Irving WL, Tanasescu R, et al. Guillain&#x2010;Barr&#xe9; syndrome variant occurring after SARS&#x2010;CoV&#x2010;2 vaccination. Ann Neurol. 2021;90:315&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">34114269</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuhorn F, Graf T, Klingebiel R, Sch&#xe4;bitz WR, Rogalewski A. Postvaccinal encephalitis after ChAdOx1 nCov&#x2010;19. Ann Neurol. 2021;90:506&#x2013;11. 10.1002/ana.26182</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26182</ArticleId><ArticleId IdType="pmc">PMC8426979</ArticleId><ArticleId IdType="pubmed">34324214</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavord S, Scully M, Hunt BJ, Lester W, Bagot C, Craven B, et al. Clinical features of vaccine&#x2010;induced immune thrombocytopenia and thrombosis. N Engl J Med. 2021. 10.1056/NEJMoa2109908</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2109908</ArticleId><ArticleId IdType="pmc">PMC10662971</ArticleId><ArticleId IdType="pubmed">34379914</ArticleId></ArticleIdList></Reference><Reference><Citation>Huynh A, Kelton JG, Arnold DM, Daka M, Nazy I. Antibody epitopes in vaccine&#x2010;induced immune thrombotic thrombocytopaenia. Nature. 2021;596(7873):565&#x2013;569.</Citation><ArticleIdList><ArticleId IdType="pubmed">34233346</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunn MP, Cornblath DR, Jacobs BC, Querol L, van Doorn PA, Hughes RA, et al. COVID&#x2010;19 vaccine and Guillain&#x2010;Barr&#xe9; syndrome: let's not leap to associations. Brain. 2021;144:357&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7799242</ArticleId><ArticleId IdType="pubmed">33313690</ArticleId></ArticleIdList></Reference><Reference><Citation>Hull M, Mered PM. Tics and TikTok: functional tics spread through social media. Mov Disord Clin Pract. 2021. 10.1002/mdc3.13267</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mdc3.13267</ArticleId><ArticleId IdType="pmc">PMC8564820</ArticleId><ArticleId IdType="pubmed">34765689</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DD, Kung CS, Perez DL. Helping the public understand adverse events associated with COVID&#x2010;19 vaccinations: lessons learned from functional neurological disorder. JAMA Neurol. 2021;78:789&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">33835153</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>